Pharmaceutical Government Contracts

A STRONG FOCUS TO PARTICIPATE AND SUPPORT GOVERNMENT CONTRACTS

CMC Pharma is a leading contract services company, focused on providing pharmaceutical drug product development services, including formulation development, analytical development, manufacturing process development, and stability services to the federal government. Our mission is to deliver our specialized scientific expertise to the government’s drug development programs, resulting in the advancement of better drug product candidates. Our services support pharmaceutical drug product development requirements at all stages of development.

CMC PHARMA HAS SUCCESSFULLY EXECUTED FORMULATION, ANALYTICAL, AND
STABILITY EFFORTS AS BOTH A PRIME AND A SUBCONTRACTOR.

  • Government Contract Experience
    • CMC Pharma has prepared proposals and executed contracts for a variety of projects and has the necessary technical expertise and corporate infrastructure to execute Government Grants and Contracts
  • Corporate priority to procure R&D funding from Federal Government Programs
    • Prepared white papers, RFIs, and proposals for various government agencies
    • Dedicated Project Manager to prepare proposals, track, and execute projects
  • Necessary corporate and accounting infrastructure to execute government contracts
    • Familiar with FARs, DFARs, and OTAs
    • Apply corporate GAAP principles
    • Systems in place for detailed labor and material expense tracking
  • CMC Pharma has initiated a corporate strategy to expand presence in developing medical countermeasures (MCMs)
  • Development of government medical countermeasures leverages CMC Pharma’s significant injectable and oral drug product development and manufacturing experience
  • Corporate mission to identify new partners to advance programs as both a prime and subcontractor.
  • Identifying, developing and manufacturing new chemical entities, reformulated, and repurposed drugs for government programs
    • Immediate release MCMs for use in autoinjectors
    • Combination Products (multiple active ingredients in single dose)
    • Reformulated products to improve stability or mission effectiveness
    • Long acting controlled release drug delivery Systems (extended protection)
  • Active member of the Medical CBRN Defense Consortium (https://www.medcbrn.org/)